Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Norda ASA

Market Cap 51Cr 5.4Cr 4.66Cr 4.28Cr 4.03Cr 7.57Cr 509.34Cr 7.63Cr 51Cr 20Cr 249.97Cr 20Cr 20Cr 864.77Cr P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 26Cr 2.78Cr 2.4Cr 2.21Cr 2.08Cr 3.9Cr 262.38Cr 3.93Cr 26Cr 10Cr 128.77Cr 10Cr 10Cr 445.47Cr EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
1 day+1.53%
3 months+1.53%
6 months+5.11%
Current year-13.60%
Current year 81
Extreme 81
86.4
1 year 80.1
Extreme 80.1
100
3 years 41
Extreme 41
100
5 years 41
Extreme 41
100
10 years 8
Extreme 8
100
Manager TitleAgeSince
Chief Executive Officer - 08/04/2013
Director TitleAgeSince
Chairman 54 31/01/2014
Director/Board Member 68 20/06/2013
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.53%-.--%+8.00%+110.73% 4.66Cr
-0.22%-1.14%-11.88%-13.09% 4.34TCr
+0.76%+9.42%+303.09%+540.82% 3.35TCr
-4.74%-6.31%+10.75%-20.99% 2.85TCr
-0.47%-0.35%+3.38%+31.20% 2.92TCr
+0.06%+4.36%+13.31%+21.11% 2.53TCr
-0.02%+10.18% - - 1.44TCr
-0.98%-1.86%+53.43%+106.06% 1.31TCr
-0.29%-4.40%+3.13%+1.69% 1.27TCr
+1.67%+1.35%+105.56%+81.16% 1.23TCr
Average -0.27%+1.35%+54.31%+95.41% 2.12TCr
Weighted average by Cap. -0.60%+1.35%+62.74%+105.16%

Financials

2023 2024
Net sales 8.69Cr 91.42L 78.86L 72.51L 68.25L 1.28Cr 86Cr 1.29Cr 8.59Cr 3.35Cr 42Cr 3.43Cr 3.36Cr 146.48Cr 37Cr 3.91Cr 3.37Cr 3.1Cr 2.92Cr 5.49Cr 369.08Cr 5.53Cr 37Cr 14Cr 181.14Cr 15Cr 14Cr 626.63Cr
Net income 3.12Cr 32.78L 28.28L 26L 24.47L 45.99L 31Cr 46.38L 3.08Cr 1.2Cr 15Cr 1.23Cr 1.2Cr 53Cr 13Cr 1.32Cr 1.14Cr 1.05Cr 98.88L 1.86Cr 125.01Cr 1.87Cr 12Cr 4.85Cr 61Cr 4.97Cr 4.87Cr 212.24Cr
Net Debt -31Cr -3.27Cr -2.82Cr -2.6Cr -2.44Cr -4.59Cr -308.92Cr -4.63Cr -31Cr -12Cr -151.61Cr -12Cr -12Cr -524.49Cr -25Cr -2.62Cr -2.26Cr -2.08Cr -1.95Cr -3.67Cr -246.96Cr -3.7Cr -25Cr -9.58Cr -121.2Cr -9.82Cr -9.61Cr -419.3Cr
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
1
  1. Stock Market
  2. Stocks
  3. NORD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!